MULTIVARIANT META-ANALYSIS OF KRAS MUTATIONS'S PREDICTIVE VALUE FOR RESPONSE TO CETUXIMAB IN COLORECTAL CANCER

被引：0
作者：
Tsoukalas, N. [1 ,2 ]
Bagos, P. [2 ]
Hamodrakas, S. [2 ]
机构：
[1] 401 Gen Army Hosp, Athens, Greece
[2] Univ Athens, Fac Biol, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
    Brudvik, K. W.
    Kopetz, S. E.
    Li, L.
    Conrad, C.
    Aloia, T. A.
    Vauthey, J. -N.
    [J]. BRITISH JOURNAL OF SURGERY, 2015, 102 (10) : 1175 - 1183
  • [32] Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab (vol 32, pg 535, 2014)
    Lee, Jeeyun
    Hong, Yong Sang
    Hong, Jung Yong
    Han, Se Won
    Kim, Tae Won
    Kang, Hye Jin
    Kim, Tae You
    Kim, Kyu-pyo
    Kim, Suk Hyung
    Do, In-Gu
    Kim, Kyoung-Mee
    Sohn, Insuk
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Cho, Yong Beom
    Lee, Woo Yong
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Park, Young Suk
    Kang, Won Ki
    [J]. INVESTIGATIONAL NEW DRUGS, 2015, 33 (01) : 269 - 270
  • [33] Re: Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
    Brandi, Giovanni
    Biasco, Guido
    Tavolari, Simona
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (16) : 1278 - 1278
  • [34] Predictive Value of Geriatric Nutritional Risk Index in Patients with Colorectal Cancer: A Meta-Analysis
    Xu, Juan
    Sun, Yimeng
    Gong, Dandan
    Fan, Yu
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 75 (01): : 24 - 32
  • [35] Prognostic Value of KRAS Mutations in the Peripheral Blood of Patients with Pancreatic Cancer: a Systematic Review and Meta-analysis
    Li, Weiwei
    Zhang, Xuejun
    Li, Yanhua
    Yue, Qiuju
    Cui, Miaohang
    Liu, Jinlong
    [J]. INDIAN JOURNAL OF SURGERY, 2022, 84 (SUPPL 2) : 476 - 484
  • [36] Prognostic Value of KRAS Mutations in the Peripheral Blood of Patients with Pancreatic Cancer: a Systematic Review and Meta-analysis
    Weiwei Li
    Xuejun Zhang
    Yanhua Li
    Qiuju Yue
    Miaohang Cui
    Jinlong Liu
    [J]. Indian Journal of Surgery, 2022, 84 : 476 - 484
  • [37] KRAS/BRAF MUTATIONS AND PTEN/P-AKT EXPRESSION AS PREDICTIVE MARKERS FOR CETUXIMAB IN JAPANESE COLORECTAL CANCER PATIENTS
    Yokota, Tomoya
    Shibata, Noriko
    Sakai, Yu
    Ura, Takashi
    Takahari, Daisuke
    Shitara, Kohei
    Shibata, Takeshi
    Muro, Kei
    Yatabe, Yasushi
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 33 - 34
  • [38] The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer
    Bruce, Jeffrey P.
    Xu, Wei
    Liu, Fei-Fei
    [J]. JAMA ONCOLOGY, 2017, 3 (04) : 491 - 492
  • [39] Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations
    Ibrahim, Ezzeldin M.
    Zekri, Jamal M.
    Bin Sadiq, Bakr M.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (06) : 713 - 721
  • [40] Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations
    Ezzeldin M. Ibrahim
    Jamal M. Zekri
    Bakr M. Bin Sadiq
    [J]. International Journal of Colorectal Disease, 2010, 25 : 713 - 721
12345